Immune Sequencing Project Will Test Technology's Ability to Diagnose Pathogen Exposure
April 12, 2011
Immune Sequencing Project Will Test Technology's Ability to Diagnose Pathogen Exposure
The three-year, proof-of-principle project is funded through a $1 million grant from the Keck Foundation. If successful, it could be a step toward the use of sequencing as a replacement for current titering methods to diagnose infection.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Adaptive TCR Raises $5.8M to Invest in Clinical Applications
June 15, 2011 / Clinical Sequencing News - HudsonAlpha Researchers to Sequence Immune Repertoires of 10K Individuals for 100 Diseases
May 24, 2011 / Clinical Sequencing News - Sequencing-Based Tropism Testing for HIV May Be Feasible, if Not Yet Commercially Viable
May 24, 2011 / Clinical Sequencing News - Adaptive Biotech Targets Year End for CLIA Certification, Assay to Detect Residual Leukemia
May 23, 2012 / Clinical Sequencing News - Swedish Project Will Sequence Tumor Exomes to Study Drug Resistance, Develop Companion Tests
August 31, 2011 / Clinical Sequencing News